Advertisement
Screener

NASDAQ:ENVB | Selling, General and Administrative Expense | Enveric Biosciences, Inc.

0.6 / 5 stars · 14/120 Roast Me

Enveric Biosciences, Inc. Selling, General and Administrative Expense

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2022-05-13

  • Enveric Biosciences, Inc. selling, general and administrative expense for the quarter ending 2022-03-31 was $2.77M, a 57.22% decline year-over-year.
  • Enveric Biosciences, Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $9.63M, a 186.52% increase year-over-year.
  • Enveric Biosciences, Inc. selling, general and administrative expense for the quarter ending 2021-09-30 was $2.12M, a 397.93% increase year-over-year.
  • Enveric Biosciences, Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $2.31M, a 222.26% increase year-over-year.
  • Enveric Biosciences, Inc. selling, general and administrative expense for fiscal 2021 was $20.50M, a 285.15% increase from fiscal 2020.
  • Enveric Biosciences, Inc. selling, general and administrative expense for fiscal 2020 was $5.32M, a 131.76% increase from fiscal 2019.
  • Enveric Biosciences, Inc. selling, general and administrative expense for fiscal 2019 was $2.30M, a 78.73% decline from fiscal 2018.
  • Enveric Biosciences, Inc. selling, general and administrative expense for fiscal 2018 was $10.79M, a 41.68% decline from fiscal 2017.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 3 month as first filedSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 6 month as first filedSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 9 month as first filedSelling, General and Administrative Expense 12 monthSelling, General and Administrative Expense 12 month as first filed
2022-03-31$2.77M
10-Q · filed 2022-05-13
$12.40M
derived: sum of 2 quarters · filed 2022-05-13
$14.53M
derived: sum of 3 quarters · filed 2022-05-13
$16.84M
derived: sum of 4 quarters · filed 2022-05-13
2021-12-31$9.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$11.76M
derived: sum of 2 quarters · filed 2022-03-31
$14.07M
derived: sum of 3 quarters · filed 2022-03-31
$20.50M
10-K · filed 2022-03-31
2021-09-30$2.12M
10-Q · filed 2021-11-15
$4.43M
derived: sum of 2 quarters · filed 2021-11-15
$10.86M
10-Q · filed 2021-11-15
$14.27M
derived: sum of 4 quarters · filed 2022-05-13
2021-06-30$2.31M
10-Q · filed 2021-08-13
$8.74M
10-Q · filed 2021-08-13
$12.14M
derived: sum of 3 quarters · filed 2022-05-13
$12.57M
derived: sum of 4 quarters · filed 2022-05-13
2021-03-31$6.47M
10-Q · filed 2022-05-13
$6.61M
10-Q · filed 2021-05-17
$9.83M
derived: sum of 2 quarters · filed 2022-05-13
$10.26M
derived: sum of 3 quarters · filed 2022-05-13
$10.98M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$3.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$3.79M
derived: sum of 2 quarters · filed 2022-03-31
$4.51M
derived: sum of 3 quarters · filed 2022-03-31
$5.32M
10-K · filed 2022-03-31
$5.44M
10-K · filed 2021-04-01
2020-09-30$426.53K
10-Q · filed 2021-11-15
$2.45M
10-Q · filed 2020-11-16
$1.14M
derived: sum of 2 quarters · filed 2021-11-15
$1.96M
10-Q · filed 2021-11-15
$7.85M
10-Q · filed 2020-11-16
-$4.80M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$716.55K
10-Q · filed 2021-08-13
$2.47M
10-Q · filed 2020-08-14
$1.53M
10-Q · filed 2021-08-13
$5.40M
10-Q · filed 2020-08-14
-$5.23M
derived: sum of 3 quarters · filed 2021-08-13
-$2.32M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$836.70K
10-Q · filed 2021-05-17
$2.92M
10-Q · filed 2020-05-15
-$5.94M
derived: sum of 2 quarters · filed 2021-05-17
-$3.04M
derived: sum of 3 quarters · filed 2021-05-17
$255.93K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$6.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01
-$3.88M
derived: sum of 2 quarters · filed 2021-04-01
-$580.77K
derived: sum of 3 quarters · filed 2021-04-01
$2.30M
10-K · filed 2021-04-01
$12.21M
10-K · filed 2020-03-25
2019-09-30$2.90M
10-Q · filed 2020-11-16
$6.20M
derived: sum of 2 quarters · filed 2020-11-16
$9.08M
10-Q · filed 2020-11-16
$11.81M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$3.30M
10-Q · filed 2020-08-14
$6.17M
10-Q · filed 2020-08-14
$8.91M
derived: sum of 3 quarters · filed 2020-08-14
$11.56M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$2.88M
10-Q · filed 2020-05-15
$5.61M
derived: sum of 2 quarters · filed 2020-08-12
$8.27M
derived: sum of 3 quarters · filed 2020-08-12
$10.79M
derived: sum of 4 quarters · filed 2020-08-12
2018-12-31$2.74M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-12
$5.39M
derived: sum of 2 quarters · filed 2020-08-12
$7.92M
derived: sum of 3 quarters · filed 2020-08-12
$10.79M
10-K/A · filed 2020-08-12
2018-09-30$2.66M
10-Q · filed 2019-11-08
$5.18M
derived: sum of 2 quarters · filed 2019-11-08
$8.06M
10-Q · filed 2019-11-08
$13.01M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30$2.52M
10-Q · filed 2019-08-14
$5.40M
10-Q · filed 2019-08-14
$10.35M
derived: sum of 3 quarters · filed 2019-08-14
$16.04M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$2.88M
10-Q · filed 2019-05-14
$7.83M
derived: sum of 2 quarters · filed 2019-05-14
$13.52M
derived: sum of 3 quarters · filed 2019-05-14
$18.36M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$4.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
$10.64M
derived: sum of 2 quarters · filed 2019-03-26
$15.48M
derived: sum of 3 quarters · filed 2019-03-26
$18.51M
10-K · filed 2019-03-26
2017-09-30$5.69M
10-Q · filed 2018-11-14
$10.53M
derived: sum of 2 quarters · filed 2018-11-14
$13.56M
10-Q · filed 2018-11-14
2017-06-30$4.84M
10-Q · filed 2018-08-14
$7.87M
10-Q · filed 2018-08-14
2017-03-31$3.03M
10-Q · filed 2018-05-15
2016-12-31$9.36M
10-K · filed 2018-04-02